![Mahalakshmi Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahalakshmi Radhakrishnan
Directeur/Membre du Conseil chez
ENTRADA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Mahalakshmi Radhakrishnan occupe le poste de Chief Medical Officer & Group Senior VP chez Biogen, Inc. Le Dr Radhakrishnan est également Senior Vice President & Head-Worldwide Medical chez Bioverativ Therapeutics, Inc. Au cours de sa carrière, le Dr Radhakrishnan a occupé les postes de vice-présidente de Biogen, Inc. et de responsable mondiale de l'unité commerciale médicale et des soins primaires chez Sanofi, ainsi que de directrice exécutive et responsable du domaine thérapeutique chez Bristol-Myers Squibb Holdings Pharma LLC. Mahalakshmi Radhakrishnan a obtenu un doctorat de l'Université de l'amitié des peuples de Russie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mahalakshmi Radhakrishnan
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2025 |
| CANDEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/06/2025 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Directeur/Membre du Conseil | 29/11/2022 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Directeur/Membre du Conseil | 05/01/2023 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/08/2024 |
Anciens postes connus de Mahalakshmi Radhakrishnan
| Sociétés | Poste | Fin |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Directeur/Membre du Conseil | 13/05/2025 |
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/03/2024 |
| SANOFI | Corporate Officer/Principal | 01/01/2019 |
| BIOASIS TECHNOLOGIES INC. | Directeur/Membre du Conseil | 27/07/2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mahalakshmi Radhakrishnan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Peoples' Friendship University of Russia
 Peoples' Friendship University of Russia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
